ENTITY
Amgen Inc

Amgen Inc (AMGN US)

189
Analysis
Health Care • United States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
bullish•Amgen Inc
•03 May 2026 02:47

Primer: Amgen Inc (AMGN US) - May 2026

Amgen is strategically navigating a period of transition, balancing the maturation of key blockbuster drugs with growth from recent acquisitions...

Logo
182 Views
Share
bullish•Amgen
•03 May 2026 02:47

Primer: Amgen (AMGN UW) - May 2026

Amgen's diversified portfolio, with 17 products annualizing over $1 billion in sales, provides a stable revenue base to offset patent...

Logo
124 Views
Share
x